• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
551.35 72 (15.03%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    496.40

  • Today’s High

    575.10

  • Open

    501.00

  • Perv Close

    479.30

  • 52W Low

    248.85

  • 52W High

    580.45

Key Indicators

  • P/E(TTM)

    27.97

  • Mar.Cap (₹Cr.)

    1,622.68

  • Div & Yield %

    0.67

  • Book Value(₹)

    143.79

  • Debt-Equity Ratio

    15.03

  • AGM Date

    29-Sep-2026

  • EPS

    19.64

  • P/E Ratio

    27.97

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    1,622.68

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    143.80

  • Sales( ₹ in Cr.)

    450.25

  • NP (in Cr.)

    55.23

  • NP Var(%)

    -23.0

  • Div%

    75.0

  • CPS (₹)

    25.90

  • EPS (₹)

    18.80

  • Traded Value (₹ in Lakhs)

    1,616.64

  • 52 Week High

    580.45

  • 52 Week Low

    248.85

  • Price BSE

    549.0

  • Price NSE

    551.00

  • Market Capital( in Cr.)

    1,616.64

  • P/C Ratio

    21.20

  • P/E Ratio

    29.30

  • Price Vs.BV

    18.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 450.25 430.53 307.09 328.91 387.96 372.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 450.25 430.53 307.09 328.91 387.96 372.82
Other Income 30.87 11.68 8.15 8.46 7.53 6.62
Stock Adjustments 24.71 7.59 -13.86 -17.29 -7.65 15.88
Total Income 505.83 449.80 301.38 320.08 387.84 395.32
EXPENDITURE :            
Raw Materials 178.07 154.38 91.57 109.21 136.55 139.52
Power and Fuel Cost 29.13 27.23 19.78 18.24 20.35 14.23
Employee Cost 74.14 60.10 53.93 53.81 59.36 57.50
Other Manufacturing Expenses 45.58 48.84 50.29 44.12 43.65 36.06
Selling and Administration Expenses 49.13 39.08 34.46 38.73 38.16 37.25
Miscellaneous Expenses 7.24 7.74 14.87 68.12 5.42 9.41
Employee Benefit Expenses 74.14 60.10 53.93 53.81 59.36 57.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 383.27 337.37 264.90 332.23 303.50 293.96
Operating Profit 122.56 112.43 36.49 -12.14 84.35 101.36
Interest 12.38 14.84 17.40 21.35 18.11 19.10
Gross Profit 110.18 97.59 19.09 -33.49 66.24 82.26
Depreciation 20.94 23.17 23.70 24.49 23.67 19.03
Profit Before Tax 89.24 74.42 -4.61 -57.98 42.57 63.23
Current Tax 14.61 13.12 14.14 -0.97 7.41 11.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 10.35 -6.32 0.00 0.00 4.92 0.00
Reported Net Profit 64.28 67.62 -18.74 -57.00 30.24 51.97
Extraordinary Items 9.05 -4.09 -11.01 -60.09 -0.02 -0.13
Adjusted Net Profit 55.23 71.71 -7.73 3.09 30.26 52.10
Adjustment below Net Profit 0.24 -0.80 0.12 9.52 -0.24 -0.04
P & L Balance brought forward 340.00 276.80 299.03 350.72 327.93 275.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.29 3.61 3.61 4.20 7.21 0.00
P & L Balance carried down 397.24 340.00 276.80 299.03 350.72 327.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 75.00 50.00 25.00 25.00 25.00 50.00
Dividend Per Share(Rs) 3.75 2.50 1.25 1.25 1.25 2.50
Earnings Per Share-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Earnings Per Share(Adj)-Unit Curr 22.42 23.18 -6.49 -19.75 10.48 18.01
Book Value 147.47 130.26 108.83 116.45 137.26 128.42
Book Value(Adj)-Unit Curr 147.47 130.26 108.83 116.45 137.26 128.42

Shareholding Pattern

  • Promoter Group

    64.09%

  • Public Share Holding

    33.36%

  • Custodian

    2.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 102,875 0.35 102,875 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 396 0.00 396 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,329 0.04 11,329 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 114,720 0.39 114,720 6
2] Non Institution
Bodies Corporate 360,983 1.23 360,383 126
Clearing Members 33,229 0.11 33,229 14
Directors of their Relatives 144,410 0.49 144,410 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 216,632 0.74 216,632 370
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 285,158 0.97 285,158 437
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,729,197 9.27 2,729,197 21
Individuals holding nominal share capital up to Rs. 1 lakh 5,634,957 19.15 5,449,348 13,988
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 12,600 0.04 12,600 2
Others 195,844 0.67 195,844 3
Sub Total 9,704,862 32.98 9,518,653 14,980
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 750,396 2.55 750,396 1
Total Shares held by Custodians and against which Depository Receipts have been issued 750,396 2.55 750,396 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,244,778 14,991

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Sanofi India 3,070.95 1,857.10 1,837.40 21.84 54.17
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77